Search results

Results 1 – 20 of 38
Advanced search

Search in namespaces:

There is a page named "Belimumab" on Wikipedia

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • Thumbnail for Belimumab
    Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte...
    31 KB (2,727 words) - 21:26, 26 January 2024
  • Thumbnail for Human Genome Sciences
    and CEO. Benlysta (belimumab) received U.S. Food and Regulatory Administration approval for use in lupus in March 2011. Belimumab was being developed...
    11 KB (1,095 words) - 21:02, 24 August 2024
  • Thumbnail for Lupus
    'off-label'. In November 2010, an FDA advisory panel recommended approving belimumab (Benlysta) as a treatment for the pain and flare-ups common in lupus....
    119 KB (13,047 words) - 02:23, 25 July 2024
  • Thumbnail for Hypersensitivity
    mycophenolate, cyclophosphamide, low dose IL-2, intravenous immunoglobulins, and belimumab. Omalizumab is a monoclonal antibody that interacts with the binding site...
    21 KB (1,860 words) - 06:18, 22 August 2024
  • Thumbnail for Lupus erythematosus
    first new drug for lupus in more than 50 years to be used in the US, belimumab. In addition to medical therapy, cognitive behavioral therapy has also...
    18 KB (1,987 words) - 07:29, 29 April 2024
  • Thumbnail for GSK plc
    US$3 billion; the companies had collaborated on developing the lupus drug Belimumab (Benlysta), albiglutide for type 2 diabetes, and darapladib for atherosclerosis...
    135 KB (12,155 words) - 03:30, 15 August 2024
  • and azathioprine. Newer targeted medications, including omalizumab and belimumab, have also been used. Urticarial vasculitis is featured prominently in...
    6 KB (715 words) - 07:24, 4 August 2023
  • Bactroban (mupirocin) Becotide (beclomethasone dipropionate) Benlysta (belimumab) Betnovate (betamethasone valerate) Blenrep (belantamab mafodotin) Breo...
    7 KB (628 words) - 18:58, 27 December 2023
  • predominantly on the surface of B cells. Like the monoclonal antibody belimumab, atacicept blocks the binding of BLyS, but it also blocks APRIL. Binding...
    6 KB (483 words) - 08:50, 31 December 2023
  • Thumbnail for Scripps Research
    Adalimumab (Humira) for rheumatoid arthritis and other inflammatory conditions Belimumab (Benlysta) for lupus Cladribine (Leustatin) for hairy cell leukemia Purification...
    24 KB (2,417 words) - 22:32, 11 August 2024
  • Thumbnail for Tumor necrosis factor
    (TL1A, TNFSF15) Recombinant proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab...
    67 KB (8,353 words) - 05:37, 25 August 2024
  • Galiximab CD147/Basigin Gavilimomab CD154 Frexalimab Ruplizumab BLyS Belimumab CAT Bertilimumab Lerdelimumab Metelimumab Integrin Natalizumab Vedolizumab...
    7 KB (299 words) - 13:45, 27 April 2024
  • L04AG01 Muromonab-CD3 L04AG02 Efalizumab L04AG03 Natalizumab L04AG04 Belimumab L04AG05 Vedolizumab L04AG06 Alemtuzumab L04AG07 Begelomab L04AG08 Ocrelizumab...
    3 KB (367 words) - 15:37, 25 January 2024
  • Thumbnail for Cambridge Antibody Technology
    marketed by Abbvie, formerly Abbott Laboratories. CAT was also behind belimumab, the anti-BlyS antibody drug marketed as Benlysta and the first new approved...
    91 KB (8,496 words) - 16:05, 19 August 2024
  • Thumbnail for Sjögren syndrome
    and neuropathy, biologic immunosuppressant drugs such as rituximab and belimumab that work via B-cell pathology are often used and have less toxic profiles...
    86 KB (9,096 words) - 22:14, 21 August 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    antigen (BCMA) Y (Withdrawn) relapsed or refractory multiple myeloma Belimumab Benlysta mab human B-cell activating factor (BAFF) Y systemic lupus erythematosus...
    136 KB (4,020 words) - 07:14, 15 August 2024
  • Immunosuppression: Abrilumab Adalimumab# Anifrolumab Atorolimumab Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab tesirine Carlumab Cemiplimab Dupilumab...
    38 KB (4,322 words) - 22:07, 23 August 2024
  • (INN) belarizine (INN) belatacept (USAN, INN) Beldin belfosdil (INN) belimumab (USAN) belinostat (USAN, INN) Belix Bellafoline Bellatal Bellergal-S beloranib...
    14 KB (621 words) - 19:38, 4 August 2024
  • Thumbnail for Tumor necrosis factor superfamily
    (TL1A, TNFSF15) Recombinant proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab...
    8 KB (316 words) - 22:44, 25 April 2024
  • Thumbnail for TNF receptor superfamily
    (TL1A, TNFSF15) Recombinant proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab...
    8 KB (501 words) - 01:30, 27 December 2023
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)